HSD17B13 and Hepatic steatosis: In mice, hepatic overexpression of human HSD17B13 increases liver TAG and cholesterol levels (87), while abrogation of the mouse Hsd17b13 gene was reported to both promote hepatic steatosis and inflammation (88) or to have limited effects on MASH (89).